ASLAN stock tumbles 54% after board votes to liquidate

seekingalpha07-17

ASLAN Pharmaceuticals (NASDAQ:ASLN) stock tumbled 54% early Wednesday after the company said it plans to liquidate and is exploring strategic options for its two primary drug assets, eblasakimab and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2452215008?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413606459/image_1413606459.jpg","is_english":true,"pubTime":"2024-07-17 22:12","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2452215008","market":"fut","top_or_hot":-1,"title":"ASLAN stock tumbles 54% after board votes to liquidate","media":"seekingalpha","content":"<div>\n<p>ASLAN Pharmaceuticals (NASDAQ:ASLN) stock tumbled 54% early Wednesday after the company said it plans to liquidate and is exploring strategic options for its two primary drug assets, eblasakimab and ...</p>\n\n<a href=\"https://seekingalpha.com/news/4125051-aslan-stock-tumbles-after-board-votes-to-liquidate\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASLAN stock tumbles 54% after board votes to liquidate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASLAN stock tumbles 54% after board votes to liquidate\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-17 22:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4125051-aslan-stock-tumbles-after-board-votes-to-liquidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ASLAN Pharmaceuticals (NASDAQ:ASLN) stock tumbled 54% early Wednesday after the company said it plans to liquidate and is exploring strategic options for its two primary drug assets, eblasakimab and ...</p>\n\n<a href=\"https://seekingalpha.com/news/4125051-aslan-stock-tumbles-after-board-votes-to-liquidate\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_MNQ","symbol_name":"微型NQ100指数","start_time":0,"source_url":"https://seekingalpha.com/news/4125051-aslan-stock-tumbles-after-board-votes-to-liquidate","article_id":"2452215008","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413606459/image_1413606459.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2452215008","pubTimestamp":1721225525,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"ASLAN Pharmaceuticals  stock tumbled 54% early Wednesday after the company said it plans to liquidate and is exploring strategic options for its two primary drug assets, eblasakimab and farudodstat. The biotech said its board voted to liquidate its only operating subsidiary, Singapore-incorporated ASLAN SG, after a strategic review of the company. As a result, all employees of ASLAN SG and its sibling subsidiary ASLAN USA have been terminated.  ASLAN’s board also voted to file for liquidation of the company under Cayman law.  The announcement comes one day after ASLAN announced its American Depositary Shares were being de-listed from Nasdaq due to non-compliance with the exchange’s minimum bid and shareholder equity requirements. ASLAN opted not to appeal the Nasdaq ruling.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4535":"淡马锡持仓","ASLN":"ASLAN PHARMACEUTICALS LIMITED SPON ADS EACH REP 25 ORD SHS (P/S)","TQQQ":"纳指三倍做多ETF","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","SQQQ":"纳指三倍做空ETF","BK4139":"生物科技","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF"},"translate_title":"董事会投票清算后阿斯兰股价暴跌54%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASLN":1,".IXIC":0.75,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"ASLAN Pharmaceuticals (NASDAQ:ASLN) stock tumbled 54% early Wednesday after the company said it plans to liquidate and is exploring strategic options for its two primary drug assets, eblasakimab and farudodstat. The biotech said its board voted to liquidate its only operating subsidiary, Singapore-incorporated ASLAN SG, after a strategic review of the company. As a result, all employees of ASLAN SG and its sibling subsidiary ASLAN USA have been terminated.  ASLAN’s board also voted to file for liquidation of the company under Cayman law.  The announcement comes one day after ASLAN announced its American Depositary Shares were being de-listed from Nasdaq due to non-compliance with the exchange’s minimum bid and shareholder equity requirements. ASLAN opted not to appeal the Nasdaq ruling.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2452215008"}